Video

Giving Patients Autonomy During Difficult Conversations

Author(s):

Joshua Richter, M.D.

A new patient-reported outcomes tool is helping to shift the way end-of-life and depression-related conversations are occurring between patients with multiple myeloma and their health care teams.

A new patient-reported outcomes tool is helping to shift the way end-of-life and depression-related conversations are occurring between patients with multiple myeloma and their health care teams, according to Joshua Richter, M.D., a hematologist/oncologist specializing in multiple myeloma at the John Theurer Cancer Center.

The tool guided patients to rank their depression and anhedonia (inability to feel pleasure), and provided meaningful insight on patients who are ready to go to palliative care or end their treatment. End-of-life discussions are never easy, but this helped to give the patient more autonomy in the conversation.

Related Videos
Image of woman with black hair.
Image of a man wearing a black suit and tie.
Image of a man with white hair and a white goatee.
Image of a woman with brown wavy hair, wearing a navy blue top.
Image of a man wearing a suit with a red bowtie.
Image of a man with rectangular glasses and a goatee.
Image of a woman with glasses and dark hair.
Image of a woman wearing a red tank top.
Image of a woman with a brown hair tied into a bun.
Related Content
Image of the FDA logo on a blue abstract background.
October 5th 2024

FDA Receives Application to Review D-VRd in Multiple Myeloma Subset

Darlene Dobkowski, MA
The biologics license application seeks potential approval of a Darzalex Faspro-based regimen for newly diagnosed multiple myeloma ineligible for transplant.
Top Headlines on CAR-T Cell Therapy
December 4th 2023

Top Headlines on CAR-T Cell Therapy

Alex Biese Brielle Benyon
From FDA concerns to a potential new drug, CAR-T cell therapies were dominating oncology headlines last week.
Illustration of cells.
September 23rd 2024

Outpatient CAR-T Cell Therapy May Be Safe in Hematologic Malignancies

Spencer Feldman
CAR-T cell therapies administered in an outpatient setting may be safe and feasible without intensive remote monitoring in hematologic malignancies.
Health Care Worker Discusses Cancer Diagnosis and Vaccine Experience While on the Frontlines of the COVID-19 Pandemic
January 13th 2022

Health Care Worker Discusses Cancer Diagnosis and Vaccine Experience While on the Frontlines of the COVID-19 Pandemic

Jamie Cesanek
In this episode of the “Cancer Horizons” podcast, a physician assistant recalls his experience as a frontline health care worker during the COVID-19 pandemic and what it was like to get diagnosed with multiple myeloma during such a chaotic time.
Image of a person holding the word "hope" with a teal ribbon for ovarian cancer.
September 20th 2024

Swimsuit Model Reveals Ovarian Cancer, Hockey Pro Shares Diagnosis and More

Alex Biese Ashley Chan
From model Bianca Balti’s ovarian cancer diagnosis to hockey pro’s testicular cancer diagnosis, here’s what’s happening in the oncology space this week.
Picture of Dr. Guillermo Garcia-Manero
September 18th 2024

Why Transfusion Independence Matters for Patients With MDS

Alex Biese
An expert explained the burden that red blood cell transfusions can place on patients with MDS.